We're sharing this complimentary copy of our full Research Report for Bioverativ (NYSE: BIVV)—20+ pages of financial analysis, investment philosophy and straightforward explanation. BIVV, our most recent closed out purchase recommendation, brought Turnaround Letter readers 95% stock profit in seven short months.Read More
Excerpted from the February 2018 Issue
While we generally like high yield bonds as a place to invest--the BofA/Merrill Lynch High Yield Index has a solid 10-year annualized total return of 7.8%, high yield returns tend to be somewhat cyclical. And, to quote an experienced high yield investor we know, the cycles "tend to end badly." The two graphs in this article suggest that we may be coming to a bumpy end to the current good times in the high yield market.Read More
Putnam and his Turnaround Letter have received a flurry of accolades and media attention over the past few weeks; and we wanted to be sure you didn't miss these recent Forbes, MarketWatch and MoneyShow.com write-ups. The Forbes piece names The Turnaround Letter's Crocs recommendation the top performer of 2017: With 90% gains, CROX beat out 100 other investment ideas included in the report; and the stock continues to have value investing appeal, according to Putnam.Read More
With the sting of Wall Street disdain battering its stock, we saw promising value investing opportunity here and felt its depreciated price failed to reflect Time's implementation of several important changes that indicated that a successful turnaround was in the works.Read More
Although George hates to choose favorites among his stock picks, this free e-report details The Turnaround Letter's "Top Five Turnaround Stocks for 2018"--including a diverse selection of value stock opportunities poised for a rebound. This is the perfect tool to grow your turnaround investing portfolio and lock in stock profit in a potentially declining market.Read More
Boeing's 111% one-year return has left three of the fabled FANG stocks in the rearview mirror, with Netflix's 114% return only narrowly beating BA shares. Boeing's gains haven't been fueled much by the company's fundamentals, but rather by expectations for clear skies in the foreseeable future. The business cycle has yet to be repealed. Cloudy skies eventually will re-appear, and gravity's renewed effect on BA shares could be unpleasant.Read More
Excerpted from the January 2018 Issue
With all the humility that any outlook requires, we can make an easy case for more stock market gains in 2018, as nearly every indicator points in this direction: Low interest rates, strengthening economies and more stimulus from the United States’ landmark tax law should foster more earnings growth and provide an overall supportive environment. But as contrarians, we see this view as being widely held and at risk of becoming the “only” view.Read More
In an era of short attention spans, 280-character tweets and investing fads like bitcoin, a top-quality book (made from actual paper) can make a wonderful and enjoyable gift. This list of high-quality reads includes great ideas for any investor. Most are considered classics, some written decades ago and others more recently. Nearly all of these titles have been read (at least once, many with margin notes) by the editors and staff of The Turnaround Letter.Read More
Specialty snack maker Amplify Snack Brands (BETR) agreed to be acquired by Hershey’s for $12/share, a 71% premium over its prior closing price. We highlighted Amplify as a strong turnaround candidate in October at its then-current price of $7.23.Read More
MoneyLife Radio's Chuck Jaffe interviews George for insight into the "specific methodology" and "discipline" behind his contrarian investing approach. Putnam discusses the troubled energy and retail sectors--with particular emphasis on what separates Macy's from Sears: M has solid assets, management and cash flow while "we're not quite sure" how SHLD can solve its mounting challenges. George emphasizes the need for investor patience in a turnaround situation, pointing out that a solid turnaround stock prospect "needs new management, assets, improved cash flow or something else that will eventually allow the stock to level off and then rebound."Read More
Identify & Profit from Distressed Investing
Turnaround Investing Blog
We're sharing this complimentary copy of our full Research Report for Bioverativ (NYSE: BIVV)—20+ pages of financial analysis, investment philosophy and straightforward explanation. BIVV, our most recent closed out purchase recommendation, brought Turnaround Letter
readers 95% stock profit in seven short months.
Harnessing Activists to Help Find Turnaround Stocks
Activist investors often produce attractive returns for their clients; and you can still use their influence to help your position as a turnaround investor in two ways: Buy a position in a stock with the expectation that an activist will soon follow or buy after an activist takes a stake.
While one of the many dozens of activist funds might find their way to selecting your particular stock, this approach is likely to be frustrating and unrewarding. A better approach is to buy after the activist makes their move. Once an activist takes a stake in a company, how do you evaluate whether it is worthwhile to follow on? Admittedly, this is a bit of an art... Learn how you can harness the power of activist investors to find market-beating turnaround stocks.
Turnaround Letter Stock Pick Named Top Performer of 2017
What Last Year's Top Stock Pickers Are Buying in 2018
This Forbes write-up follows up on the recent Top Stock Tips report--naming The Turnaround Letter's Crocs recommendation the top performer of 2017: With 90% gains, CROX beat out 100 other investment ideas included in the report; and the stock continues to have value investing appeal, according to Putnam.
George notes, "We see additional upside for the stock in 2018 as management's efforts continue to bear fruit, though the gains will likely be more muted than we saw in 2017."
Copyright © All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing.